Budd-Chiari syndrome with underlying homozygous factor V Leiden and heterozygous methylenetetrahydrofolate reductase mutations

被引：0
|
作者：
Kassem A. Barada
Cecilio R. Azar
Zaher K. Otrock
Ali T. Taher
机构：
[1] American University of Beirut Medical Center,Department of Internal Medicine
[2] American University of Beirut,Haematology
来源：
Journal of Gastroenterology | 2005年 / 40卷
关键词：
Public Health; Internal Medicine; Factor Versus; Methylenetetrahydrofolate; Methylenetetrahydrofolate Reductase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1002 / 1003
页数：1
相关论文
共 50 条
  • [41] Pregnancy: a risk factor for Budd-Chiari syndrome?
    Rautou, P-E
    Plessier, A.
    Bernuau, J.
    Denninger, M-H
    Moucari, R.
    Valla, D.
    GUT, 2009, 58 (04) : 606 - 608
  • [42] Budd-Chiari syndrome in a young female with factor V Leiden mutation:: Successful treatment with lepirudin, a direct thrombin inhibitor
    Salmela, Birgitta
    Nordin, Arno
    Vuoristo, Matti
    Makisalo, Heikki
    Numminen, Kirsti
    Lassila, Riitta
    THROMBOSIS RESEARCH, 2008, 121 (06) : 769 - 772
  • [43] Reply to: "Calreticulin mutations and their importance in Budd-Chiari syndrome"
    Poisson, Johanne
    Turon, Fanny
    Marzac, Christophe
    Valla, Dominique-Charles
    Garcia-Pagan, Juan-Carlos
    Rautou, Pierre-Emmanuel
    JOURNAL OF HEPATOLOGY, 2017, 67 (05) : 1112 - 1113
  • [44] CALR mutations in Chinese Budd-Chiari syndrome patients
    Zhang, Peijin
    Ma, He
    Min, QiFen
    Zu, Maoheng
    Lu, Zhaojun
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (03) : 361 - 362
  • [45] Papillophlebitis Associated With Coexisting Heterozygous Mutations of Factor V Leiden and Methylenetetrahydrofolate Reductase Enzyme-(C677T)
    Ntora, Efthalia
    Dalianis, Georgios
    Terzidou, Chryssa
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
  • [46] Factor V Leiden and methylenetetrahydrofolate reductase mutations in patients with recurrent hemodialysis shunt thrombosis
    Ouseph, R
    Barker, R
    Joseph, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0847 - A0847
  • [47] Budd-Chiari syndrome induced by hormonal oral contraception in the patient with congenital thrombophilia - factor V Leiden mutation - a case report
    Samborek, Malgorzata
    Drosdzol, Agnieszka
    Stojko, Rafal
    Wilk, Krzysztof
    Witek, Andrzej
    GINEKOLOGIA POLSKA, 2008, 79 (10) : 702 - 705
  • [48] Risk of Budd-Chiari Syndrome Associated with Factor V Leiden and G20210A Prothrombin Mutation: A Meta-Analysis
    Zhang, Peijin
    Zhang, Jing
    Sun, Guixiang
    Gao, Xiuyin
    Wang, Hui
    Yan, Wenjun
    Xu, Hao
    Zu, Maoheng
    Ma, He
    Wang, Wei
    Lu, Zhaojun
    PLOS ONE, 2014, 9 (04):
  • [49] Hyperhomocysteinemia is a risk factor for Budd-Chiari syndrome.
    Karasu, Z
    Colak, Y
    Can, C
    Akarca, U
    Gunsar, F
    Ersoz, G
    Tokat, Y
    Evinc, A
    Kilic, M
    Batur, Y
    HEPATOLOGY, 2002, 36 (04) : 709A - 709A
  • [50] Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome
    Hoekstra, Jildou
    Guimaraes, Ana H. C.
    Leebeek, Frank W. G.
    Murad, Sarwa Darwish
    Malfliet, Joyce J. M. C.
    Plessier, Aurelie
    Hernandez-Guerra, Manuel
    Langlet, Philippe
    Elias, Elwyn
    Trebicka, Jonel
    Primignani, Massimo
    Garcia-Pagan, Juan-Carlos
    Valla, Dominique C.
    Rijken, Dingeman C.
    Janssen, Harry L. A.
    BLOOD, 2010, 115 (02) : 388 - 395
12345